We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+17.25%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
AUM
$354M
AUM Growth
+$43.2M
Cap. Flow
+$30.3M
Cap. Flow %
8.54%
Top 10 Hldgs %
31.72%
Holding
1,674
New
354
Increased
213
Reduced
237
Closed
746

Sector Composition

Rank Sector Weight
1 Healthcare 20.04%
2 Financials 17.75%
3 Technology 15.74%
4 Industrials 7.52%
5 Consumer Discretionary 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
76
Merck
MRK
$322B
$1.07M 0.3%
+10,200
New +$957K
XLV icon
77
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
$1.06M 0.3%
6,886
-6,760
-50% -$1.01M
AUR icon
78
Aurora
AUR
$13.6B
$1.06M 0.3%
275,093
+78,534
+40% +$360K
TSLY icon
79
YieldMax TSLA Option Income Strategy ETF
TSLY
$669M
$1.04M 0.29%
27,640
+27,040
+4,507% +$1.09M
GE icon
80
GE Aerospace
GE
$382B
$1.03M 0.29%
3,360
-1,546
-32% -$466K
UWMC icon
81
UWM Holdings
UWMC
$2.45B
$1.03M 0.29%
+235,000
New +$1.26M
BACC
82
Blue Acquisition Corp
BACC
$293M
$1.01M 0.29%
+99,325
New +$1.01M
STX icon
83
Seagate
STX
$186B
$1.01M 0.29%
3,672
-8,137
-69% -$2.11M
DPZ icon
84
Domino's
DPZ
$11.8B
$1M 0.28%
+2,400
New +$1M
METC icon
85
Ramaco Resources Class A
METC
$647M
$992K 0.28%
55,146
+31,668
+135% +$832K
MSOS icon
86
AdvisorShares Pure US Cannabis ETF
MSOS
$930M
$982K 0.28%
208,146
+21,655
+12% +$96.5K
SBSW icon
87
Sibanye-Stillwater
SBSW
$7.51B
$940K 0.27%
65,990
-363,110
-85% -$4.39M
WRBY icon
88
Warby Parker
WRBY
$3.1B
$900K 0.25%
+41,326
New +$899K
NTES icon
89
NetEase
NTES
$81.9B
$894K 0.25%
+6,500
New +$923K
NIO icon
90
NIO
NIO
$11.6B
$892K 0.25%
+175,000
New +$1.08M
ENPH icon
91
Enphase Energy
ENPH
$5.59B
$884K 0.25%
27,582
+26,900
+3,944% +$871K
ASTS icon
92
AST SpaceMobile
ASTS
$21.4B
$874K 0.25%
12,044
-12,044
-50% -$860K
MDT icon
93
Medtronic
MDT
$116B
$864K 0.24%
9,000
+8,723
+3,149% +$847K
SGMT icon
94
Sagimet Biosciences
SGMT
$592M
$845K 0.24%
142,881
+32,231
+29% +$232K
CEG icon
95
Constellation Energy
CEG
$98.6B
$835K 0.24%
2,366
-3,299
-58% -$1.2M
CAH icon
96
Cardinal Health
CAH
$55.9B
$822K 0.23%
+4,000
New +$753K
OKTA icon
97
Okta
OKTA
$26.1B
$821K 0.23%
9,500
+319
+3% +$27.8K
SVII
98
DELISTED
Spring Valley Acquisition Corp II
SVII
$811K 0.23%
68,344
-75,028
-52% -$967K
KINS icon
99
Kingstone Companies
KINS
$276M
$809K 0.23%
48,127
+26,527
+123% +$404K
RTO icon
100
Rentokil
RTO
$12.4B
$789K 0.22%
26,800
+20,000
+294% +$556K

Similar funds

FNY Investment Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, FNY Investment Advisers held 1,674 positions worth $354M, up 14% from $311M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FNY Investment Advisers deployed $30.3M of net new capital in Q4 2025, opening 354 new positions and adding to 213 existing holdings. Its largest new stake was Cidara Therapeutics: 145,533 shares worth $32.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Sibanye-Stillwater, an estimated $4.39M trimmed.

  • FNY Investment Advisers's largest Q4 2025 buy was Cidara Therapeutics: 145,533 shares worth $32.1M.
  • FNY Investment Advisers added most to Morgan Stanley in Q4 2025, an estimated $6.17M increase.
  • FNY Investment Advisers's biggest Q4 2025 reduction was Sibanye-Stillwater, cutting an estimated $4.39M.
  • FNY Investment Advisers fully exited Verona Pharma in Q4 2025, selling an estimated $15.8M.
  • FNY Investment Advisers's ten largest holdings make up 32% of its $354M portfolio in Q4 2025.
  • FNY Investment Advisers opened 354 new positions and closed 746 in Q4 2025.
  • FNY Investment Advisers's portfolio value rose 14% quarter-over-quarter to $354M.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.